Nichols & Pratt Advisers’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,183
| Closed | -$240K | – | 108 |
|
|
2025
Q3 | $240K | Sell |
3,183
-99,245
| -97% | -$6.8M | 0.02% | 98 |
|
|
2025
Q2 | $7.07M | Buy |
102,428
+116
| +0.1% | +$7.61K | 0.47% | 35 |
|
|
2025
Q1 | $6.93M | Sell |
102,312
-7,627
| -7% | -$456K | 0.47% | 35 |
|
|
2024
Q4 | $4.94M | Sell |
109,939
-41,026
| -27% | -$2.3M | 0.33% | 38 |
|
|
2024
Q3 | $9.49M | Sell |
150,965
-32,415
| -18% | -$1.89M | 0.61% | 34 |
|
|
2024
Q2 | $10.8M | Sell |
183,380
-26,199
| -13% | -$1.64M | 0.73% | 33 |
|
|
2024
Q1 | $16.7M | Sell |
209,579
-119,362
| -36% | -$9.12M | 1.13% | 27 |
|
|
2023
Q4 | $26M | Sell |
328,941
-7,970
| -2% | -$567K | 1.85% | 22 |
|
|
2023
Q3 | $23.5M | Sell |
336,911
-295
| -0.1% | -$20.9K | 1.78% | 21 |
|
|
2023
Q2 | $23.3M | Sell |
337,206
-1,994
| -0.6% | -$142K | 1.7% | 21 |
|
|
2023
Q1 | $25.2M | Sell |
339,200
-3,063
| -0.9% | -$257K | 1.94% | 17 |
|
|
2022
Q4 | $31.9M | Sell |
342,263
-300
| -0.1% | -$28.9K | 2.56% | 15 |
|
|
2022
Q3 | $32.7M | Buy |
342,563
+255
| +0.1% | +$25.2K | 2.9% | 10 |
|
|
2022
Q2 | $31.7M | Buy |
342,308
+1,165
| +0.3% | +$114K | 2.6% | 11 |
|
|
2022
Q1 | $34.5M | Sell |
341,143
-95
| -0% | -$9.98K | 2.5% | 13 |
|
|
2021
Q4 | $35.2M | Buy |
341,238
+167
| +0% | +$15.4K | 2.43% | 12 |
|
|
2021
Q3 | $28.7M | Sell |
341,071
-355
| -0.1% | -$29.7K | 2.17% | 14 |
|
|
2021
Q2 | $28.5M | Buy |
341,426
+1,005
| +0.3% | +$82.3K | 2.15% | 15 |
|
|
2021
Q1 | $25.6M | Buy |
340,421
+460
| +0.1% | +$33.5K | 1.99% | 18 |
|
|
2020
Q4 | $23.3M | Buy |
339,961
+8,198
| +2% | +$533K | 1.85% | 18 |
|
|
2020
Q3 | $19.4M | Buy |
331,763
+6,356
| +2% | +$395K | 1.67% | 20 |
|
|
2020
Q2 | $21.1M | Buy |
325,407
+24,238
| +8% | +$1.53M | 1.89% | 17 |
|
|
2020
Q1 | $17.8M | Buy |
301,169
+58,720
| +24% | +$3.92M | 1.79% | 20 |
|
|
2019
Q4 | $18M | Buy |
242,449
+11,879
| +5% | +$834K | 1.48% | 23 |
|
|
2019
Q3 | $14.5M | Buy |
230,570
+7,924
| +4% | +$470K | 1.19% | 29 |
|
|
2019
Q2 | $12.1M | Buy |
222,646
+7,404
| +3% | +$399K | 1% | 33 |
|
|
2019
Q1 | $11.6M | Sell |
215,242
-3,466
| -2% | -$214K | 0.98% | 35 |
|
|
2018
Q4 | $14.3M | Sell |
218,708
-4,509
| -2% | -$337K | 1.35% | 25 |
|
|
2018
Q3 | $17.6M | Buy |
223,217
+1,886
| +0.9% | +$135K | 1.46% | 26 |
|
|
2018
Q2 | $14.2M | Buy |
221,331
+2,921
| +1% | +$192K | 1.27% | 31 |
|
|
2018
Q1 | $13.6M | Buy |
218,410
+2,055
| +0.9% | +$147K | 1.23% | 30 |
|
|
2017
Q4 | $15.7M | Sell |
216,355
-7,610
| -3% | -$553K | 1.36% | 28 |
|
|
2017
Q3 | $18.2M | Sell |
223,965
-2,050
| -0.9% | -$162K | 1.63% | 24 |
|
|
2017
Q2 | $18.2M | Buy |
226,015
+2,600
| +1% | +$205K | 1.66% | 21 |
|
|
2017
Q1 | $17.5M | Buy |
223,415
+16,970
| +8% | +$1.35M | 1.62% | 24 |
|
|
2016
Q4 | $16.3M | Sell |
206,445
-3,641
| -2% | -$295K | 1.54% | 25 |
|
|
2016
Q3 | $18.7M | Buy |
210,086
+15,421
| +8% | +$1.46M | 1.72% | 18 |
|
|
2016
Q2 | $18.6M | Buy |
194,665
+18,265
| +10% | +$1.82M | 1.69% | 17 |
|
|
2016
Q1 | $18.3M | Buy |
176,400
+14,680
| +9% | +$1.43M | 1.69% | 17 |
|
|
2015
Q4 | $15.8M | Buy |
161,720
+5,390
| +3% | +$528K | 1.52% | 22 |
|
|
2015
Q3 | $15.1M | Buy |
156,330
+38,275
| +32% | +$4.02M | 1.51% | 22 |
|
|
2015
Q2 | $12.4M | Buy |
118,055
+23,360
| +25% | +$2.39M | 1.15% | 30 |
|
|
2015
Q1 | $9.77M | Buy |
94,695
+2,746
| +3% | +$278K | 0.89% | 33 |
|
|
2014
Q4 | $8.85M | Buy |
91,949
+490
| +0.5% | +$43.2K | 0.78% | 37 |
|
|
2014
Q3 | $7.28M | Sell |
91,459
-400
| -0.4% | -$31.5K | 0.65% | 40 |
|
|
2014
Q2 | $6.93M | Buy |
91,859
+7,248
| +9% | +$548K | 0.6% | 40 |
|
|
2014
Q1 | $6.33M | Buy |
84,611
+17,490
| +26% | +$1.24M | 0.57% | 42 |
|
|
2013
Q4 | $4.8M | Sell |
67,121
-1,400
| -2% | -$90K | 0.45% | 47 |
|
|
2013
Q3 | $3.89M | Buy |
68,521
+1,715
| +3% | +$102K | 0.39% | 48 |
|
|
2013
Q2 | $3.82M | Buy |
+66,806
| New | +$3.87M | 0.4% | 48 |
|
Other funds holding CVS
Nichols & Pratt Advisers's CVS Position: Q4 2025 in Review
Nichols & Pratt Advisers sold out of CVS Health (CVS) in Q4 2025, closing a stake of 3,183 shares — an estimated $240K sold.
Nichols & Pratt Advisers first reported a position in CVS in Q2 2013 and held it in 50 quarters. The position peaked at $35.2M in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.
- Nichols & Pratt Advisers reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
- Nichols & Pratt Advisers sold 3,183 CVS Health shares in Q4 2025, an estimated $240K.
- Nichols & Pratt Advisers first reported a position in CVS Health in Q2 2013 and held it in 50 quarters.
- Nichols & Pratt Advisers's CVS Health position peaked at $35.2M in Q4 2021.
- 1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.
Based on Nichols & Pratt Advisers's 13F filing for Q4 2025, filed 29 Jan 2026.